Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Impact
        • Technologies
        • Commercialisation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research.

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in memory
        • Advise on our research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Careers
        • Study opportunities
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events.

        • News
        • Statements
        • Events
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges.

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Meet Dr Katrina Frankcombe

Meet Dr Katrina Frankcombe

Date time 24 August, 2018
News Type News type Profiles
Dr Katrina Frankcombe
Hi, I'm Katrina and I'm in charge of Translation and Commercialisation at Centenary.

Centenary’s scientists do incredible work – making medical breakthroughs in the lab. But how do those breakthroughs come to be real-life health solutions? That’s where I come in.

I’m in charge of Translation and Commercialisation – a large part of my role requires me to look at what research is being undertaken at Centenary, identify opportunities where it could be translated into diagnostics, therapeutics or other health outcomes and then help see that through.

While I studied medicinal chemistry at university, it’s a completely different level here. The scientists are talking about signalling processes and physiological effects, which I don’t have a background in. It can be quite challenging and Centenary’s scientists need to ‘dumb’ it down a bit for me. But that’s also good because most of the people I talk to will be more business people, so they don’t necessarily have that background either.
It hasn’t always been about science. I’ve had a diverse career – even moonlighting as a nightclub manager!

I went to the UK to do a post-doctorate at Cambridge University, but I became a bit disillusioned with academia. So, I left and managed a nightclub for three years. I went back into science, working for a biotech company, before moving into business development.

Download my full story

Themes

  • Cancer Innovations

    Cancer Innovations
  • Cardiovascular Research

    Cardiovascular Research
  • Inflammation

    Inflammation

People

  • Dr Katrina Frankcombe

    Translation and Commercialisation Manager

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Recent Stories

  • Emerging class of antibiotics to tackle global tuberculosis crisis

    Researchers from the University of Sydney and the Centenary Institute have discovered how a promising class of experimental antibiotics disrupts the bacterium that causes tuberculosis (TB), paving the way for urgently needed new treatments.
    News Type: Media release
    Date 27 Feb 2026
  • Blood test discovery could help identify head and neck cancer patients at higher risk of relapse

    Researchers at the Centenary Institute, Chris O’Brien Lifehouse, NSW Health Pathology and Royal Prince Alfred Hospital have found a potential new way to help doctors identify which head and neck cancer patients may be at higher risk of their cancer returning, using a simple blood test.
    News Type: Media release
    Date 25 Feb 2026
  • New FAP-Index could transform early detection of severe liver disease

    Researchers from the Centenary Institute have developed a new diagnostic tool, the FAP-Index, that could significantly improve how doctors identify people at risk of serious liver damage caused by metabolic fatty liver disease. The condition affects around one in three Australians with cases projected to increase by 25% to over 7 million by 2030.
    News Type: Media release
    Date 20 Feb 2026
  • First‑of‑its‑kind AI platform to improve cancer treatment decisions

    Centenary researchers have been awarded funding to commercialise a first‑of‑its‑kind medical AI platform designed to improve treatment decisions and reduce unnecessary surgeries for Australian cancer patients. The project, funded through the Australian Government’s Australia’s Economic Accelerator (AEA) Ignite program and led by Dr Yagiz Aksoy, Senior Clinical Research Fellow at Centenary’s Centre for Biomedical AI, ...
    News Type: Research News
    Date 19 Feb 2026

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About us
  • Governance
  • Corporate information

Research

  • Our researchers
  • News

Careers & studies

  • Career opportunities
  • Student opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement
  • Staff Intranet

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram